Metformin

📧 EM Note Newsletter https://forms.gle/8boToiKDXVE3V8U19 Signup to get free weekly PDF via email. PS: Please join our membership for more perks (members can request for specific PDF file by posting in the EM Note YouTube Membership section). Homepage: EMNote.org ■ 🚩Membership: https://tinyurl.com/joinemnote 🚩ACLS Lecture: https://tinyurl.com/emnoteacls Derived from the French lilac, metformin serves as the primary first-line medication for treating Type 2 Diabetes by reducing hepatic glucose production and improving insulin sensitivity. These sources highlight that the drug functions as an insulin facilitator rather than a stimulator, which prevents dangerous drops in blood sugar during treatment. Beyond glycemic control, the text explores off-label applications such as managing PCOS, prediabetes, and potential anti-aging benefits currently under investigation. Clinical guidance emphasizes a gradual dosage increase and the use of extended-release versions to mitigate common gastrointestinal side effects. Proper administration requires careful monitoring of renal function, as the medication is contraindicated for patients with severe kidney impairment to avoid the rare risk of lactic acidosis. Ultimately, the drug is presented as a cost-effective, multitargeted metabolic modulator with a robust safety profile and expanding therapeutic potential.